26 results
8-K
TSHA
Taysha Gene Therapies Inc
1 Nov 23
Departure of Directors or Certain Officers
4:02pm
”) and as a member of each of the Nominating and Corporate Governance Committee of the Board (the “Nominating and Corporate Governance Committee”) and the Compensation … Committee and an additional $4,000 annual retainer for her service on the Nominating and Corporate Governance Committee.
At each annual stockholder
8-K
TSHA
Taysha Gene Therapies Inc
22 Jun 23
Departure of Directors or Certain Officers
5:12pm
of the Nominating and Corporate Governance Committee of the Board (the “Nominating and Corporate Governance Committee”) and a member of the Compensation Committee … as director, an additional $8,000 annual retainer for his service as chair of the Nominating and Corporate Governance Committee and an additional $5,000
8-K
n1h rmka1c
27 Apr 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:07pm
PRE 14A
beqtvzl9bicyy tmoyk3
27 Apr 23
Preliminary proxy
4:03pm
8-K
EX-1.1
nw72n e9q
27 Oct 22
Taysha Announces Pricing of Public Offering of Common Stock
5:18pm
S-3
EX-1.2
xgd4d1
5 Oct 21
Shelf registration
5:04pm
DEF 14A
xdbm9s 00jmmxrigfff
29 Apr 21
Definitive proxy
5:03pm
10-K
6zwdga2aq nhz8c
3 Mar 21
Annual report
9:00am
8-K
orfo3x a6u
24 Nov 20
Taysha Gene Therapies Adds Industry-Leading Gene Therapy Executives to Board of Directors
7:15am
10-Q
9vak7gaa75oy vz
12 Nov 20
Quarterly report
4:27pm
424B4
vkrow
25 Sep 20
Prospectus supplement with pricing info
12:00am